Parallel Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Parallel Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-267	Closed	-$25K	–	3422
2021 Q4	$25K	Buy	267 +194	+266%	+$12.8K	﹤0.01%	1687
2021 Q3	$4K	Sell	73 -92	-56%	-$5.43K	﹤0.01%	2528
2021 Q2	$11K	Buy	+165	New	+$10.8K	﹤0.01%	1981
2021 Q1	–	Sell	-3	Closed	–	–	2960
2020 Q4	$0	Buy	+3	New	+$225	﹤0.01%	2793

Parallel Advisors's ARNA Position: Q1 2022 in Review

Parallel Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 267 shares — an estimated $25K sold.

Parallel Advisors first reported a position in ARNA in Q4 2020 and held it in 4 quarters. The position peaked at $25K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Parallel Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Parallel Advisors sold 267 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $25K.
Parallel Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 4 quarters.
Parallel Advisors's Arena Pharmaceuticals Inc position peaked at $25K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.